SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3fvc'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A4G_B_ZMRB466_1
(NEURAMINIDASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 GLU A 289
ARG A 291
GLU A 242
ASN A 240
ARG A 273
None
1.37A 1a4gB-3fvcA:
undetectable
1a4gB-3fvcA:
19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NNC_A_ZMRA479_1
(NEURAMINIDASE N9)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 GLU A 289
ARG A 291
GLU A 242
ASN A 240
ARG A 273
None
1.27A 1nncA-3fvcA:
undetectable
1nncA-3fvcA:
20.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1YKI_A_NFZA1219_1
(OXYGEN-INSENSITIVE
NAD(P)H
NITROREDUCTASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
4 / 8 GLU A 321
GLY A 322
THR A 306
PHE A 303
None
1.04A 1ykiA-3fvcA:
undetectable
1ykiB-3fvcA:
undetectable
1ykiA-3fvcA:
14.95
1ykiB-3fvcA:
14.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1YKI_B_NFZB2219_1
(OXYGEN-INSENSITIVE
NAD(P)H
NITROREDUCTASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
4 / 8 THR A 306
PHE A 303
GLU A 321
GLY A 322
None
1.06A 1ykiA-3fvcA:
undetectable
1ykiB-3fvcA:
undetectable
1ykiA-3fvcA:
14.95
1ykiB-3fvcA:
14.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1YKI_C_NFZC3219_1
(OXYGEN-INSENSITIVE
NAD(P)H
NITROREDUCTASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
4 / 8 GLU A 321
GLY A 322
THR A 306
PHE A 303
None
1.07A 1ykiC-3fvcA:
undetectable
1ykiD-3fvcA:
undetectable
1ykiC-3fvcA:
14.95
1ykiD-3fvcA:
14.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1YKI_D_NFZD4219_1
(OXYGEN-INSENSITIVE
NAD(P)H
NITROREDUCTASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
4 / 8 THR A 306
PHE A 303
GLU A 321
GLY A 322
None
1.04A 1ykiC-3fvcA:
undetectable
1ykiD-3fvcA:
undetectable
1ykiC-3fvcA:
14.95
1ykiD-3fvcA:
14.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2CML_A_ZMRA1477_1
(NEURAMINIDASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 GLU A 289
ARG A 291
GLU A 242
ASN A 240
ARG A 273
None
1.28A 2cmlA-3fvcA:
undetectable
2cmlA-3fvcA:
20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2CML_B_ZMRB2477_1
(NEURAMINIDASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 GLU A 289
ARG A 291
GLU A 242
ASN A 240
ARG A 273
None
1.26A 2cmlB-3fvcA:
undetectable
2cmlB-3fvcA:
20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2CML_C_ZMRC3477_1
(NEURAMINIDASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 GLU A 289
ARG A 291
GLU A 242
ASN A 240
ARG A 273
None
1.24A 2cmlC-3fvcA:
undetectable
2cmlC-3fvcA:
20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2CML_D_ZMRD4477_1
(NEURAMINIDASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 GLU A 289
ARG A 291
GLU A 242
ASN A 240
ARG A 273
None
1.30A 2cmlD-3fvcA:
undetectable
2cmlD-3fvcA:
20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FJ1_A_CTCA222_0
(TETRACYCLINE
REPRESSOR PROTEIN
CLASS D)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 SER A 560
THR A 535
VAL A 536
LEU A 572
ILE A 578
None
1.36A 2fj1A-3fvcA:
undetectable
2fj1A-3fvcA:
15.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X2I_C_QPSC1060_1
(ALPHA-1,4-GLUCAN
LYASE ISOZYME 1)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 THR A 370
THR A 311
VAL A 332
GLY A 333
GLN A 366
None
1.27A 2x2iC-3fvcA:
undetectable
2x2iC-3fvcA:
21.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3B7E_A_ZMRA1001_1
(NEURAMINIDASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 GLU A 289
ARG A 291
GLU A 242
ASN A 240
ARG A 273
None
1.27A 3b7eA-3fvcA:
undetectable
3b7eA-3fvcA:
19.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3B7E_B_ZMRB1002_1
(NEURAMINIDASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 GLU A 289
ARG A 291
GLU A 242
ASN A 240
ARG A 273
None
1.27A 3b7eB-3fvcA:
undetectable
3b7eB-3fvcA:
19.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SAN_A_ZMRA901_1
(NEURAMINIDASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 GLU A 289
ARG A 291
GLU A 242
ASN A 240
ARG A 273
None
1.25A 3sanA-3fvcA:
undetectable
3sanA-3fvcA:
19.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SAN_B_ZMRB901_1
(NEURAMINIDASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 GLU A 289
ARG A 291
GLU A 242
ASN A 240
ARG A 273
None
1.24A 3sanB-3fvcA:
undetectable
3sanB-3fvcA:
19.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TI5_A_ZMRA1002_1
(NEURAMINIDASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 GLU A 289
ARG A 291
GLU A 242
ASN A 240
ARG A 273
None
1.26A 3ti5A-3fvcA:
undetectable
3ti5A-3fvcA:
21.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TI5_B_ZMRB1002_1
(NEURAMINIDASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 GLU A 289
ARG A 291
GLU A 242
ASN A 240
ARG A 273
None
1.25A 3ti5B-3fvcA:
undetectable
3ti5B-3fvcA:
21.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TIC_B_ZMRB1002_1
(NEURAMINIDASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 GLU A 289
ARG A 291
GLU A 242
ASN A 240
ARG A 273
None
1.24A 3ticB-3fvcA:
undetectable
3ticB-3fvcA:
20.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TIC_C_ZMRC1002_1
(NEURAMINIDASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 GLU A 289
ARG A 291
GLU A 242
ASN A 240
ARG A 273
None
1.24A 3ticC-3fvcA:
undetectable
3ticC-3fvcA:
20.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TIC_D_ZMRD1002_1
(NEURAMINIDASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 GLU A 289
ARG A 291
GLU A 242
ASN A 240
ARG A 273
None
1.24A 3ticD-3fvcA:
undetectable
3ticD-3fvcA:
20.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TTR_A_LQZA90_1
(LACTOTRANSFERRIN)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
3 / 3 PRO A 170
THR A 171
LEU A 207
None
0.78A 3ttrA-3fvcA:
undetectable
3ttrA-3fvcA:
20.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4B7Q_A_ZMRA601_1
(NEURAMINIDASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 GLU A 289
ARG A 291
GLU A 242
ASN A 240
ARG A 273
None
1.20A 4b7qA-3fvcA:
undetectable
4b7qA-3fvcA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4B7Q_B_ZMRB601_1
(NEURAMINIDASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 GLU A 289
ARG A 291
GLU A 242
ASN A 240
ARG A 273
None
1.23A 4b7qB-3fvcA:
undetectable
4b7qB-3fvcA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4B7Q_C_ZMRC601_1
(NEURAMINIDASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 GLU A 289
ARG A 291
GLU A 242
ASN A 240
ARG A 273
None
1.30A 4b7qC-3fvcA:
undetectable
4b7qC-3fvcA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4B7Q_D_ZMRD601_1
(NEURAMINIDASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 GLU A 289
ARG A 291
GLU A 242
ASN A 240
ARG A 273
None
1.31A 4b7qD-3fvcA:
undetectable
4b7qD-3fvcA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CPN_A_ZMRA700_1
(NEURAMINIDASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 GLU A 289
ARG A 291
GLU A 242
ASN A 240
ARG A 273
None
1.34A 4cpnA-3fvcA:
undetectable
4cpnA-3fvcA:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CPZ_A_ZMRA1471_1
(NEURAMINIDASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 GLU A 289
ARG A 291
GLU A 242
ASN A 240
ARG A 273
None
1.35A 4cpzA-3fvcA:
undetectable
4cpzA-3fvcA:
21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CPZ_B_ZMRB1471_1
(NEURAMINIDASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 GLU A 289
ARG A 291
GLU A 242
ASN A 240
ARG A 273
None
1.32A 4cpzB-3fvcA:
undetectable
4cpzB-3fvcA:
21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CPZ_C_ZMRC1470_1
(NEURAMINIDASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 GLU A 289
ARG A 291
GLU A 242
ASN A 240
ARG A 273
None
1.37A 4cpzC-3fvcA:
undetectable
4cpzC-3fvcA:
21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CPZ_D_ZMRD1471_1
(NEURAMINIDASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 GLU A 289
ARG A 291
GLU A 242
ASN A 240
ARG A 273
None
1.34A 4cpzD-3fvcA:
undetectable
4cpzD-3fvcA:
21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CPZ_F_ZMRF1470_1
(NEURAMINIDASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 GLU A 289
ARG A 291
GLU A 242
ASN A 240
ARG A 273
None
1.38A 4cpzF-3fvcA:
undetectable
4cpzF-3fvcA:
21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CPZ_G_ZMRG1471_1
(NEURAMINIDASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 GLU A 289
ARG A 291
GLU A 242
ASN A 240
ARG A 273
None
1.36A 4cpzG-3fvcA:
undetectable
4cpzG-3fvcA:
21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CPZ_H_ZMRH1470_1
(NEURAMINIDASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 GLU A 289
ARG A 291
GLU A 242
ASN A 240
ARG A 273
None
1.34A 4cpzH-3fvcA:
undetectable
4cpzH-3fvcA:
21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MK4_B_CHDB504_0
(FERROCHELATASE,
MITOCHONDRIAL)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
3 / 3 LEU A 107
ILE A 108
ARG A 201
None
0.69A 4mk4B-3fvcA:
undetectable
4mk4B-3fvcA:
19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MWR_A_ZMRA513_1
(NEURAMINIDASE)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
5 / 12 GLU A 289
ARG A 291
GLU A 242
ASN A 240
ARG A 273
None
1.25A 4mwrA-3fvcA:
undetectable
4mwrA-3fvcA:
20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VKQ_A_PCFA1805_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
4 / 7 HIS A  77
ILE A 307
SER A 314
THR A 311
None
1.05A 5vkqA-3fvcA:
undetectable
5vkqD-3fvcA:
undetectable
5vkqA-3fvcA:
17.06
5vkqD-3fvcA:
17.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VKQ_B_PCFB1802_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
4 / 7 SER A 314
THR A 311
HIS A  77
ILE A 307
None
1.06A 5vkqA-3fvcA:
undetectable
5vkqB-3fvcA:
undetectable
5vkqA-3fvcA:
17.06
5vkqB-3fvcA:
17.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VKQ_C_PCFC1803_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
4 / 8 SER A 314
THR A 311
HIS A  77
ILE A 307
None
1.07A 5vkqB-3fvcA:
undetectable
5vkqC-3fvcA:
undetectable
5vkqB-3fvcA:
17.06
5vkqC-3fvcA:
17.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VKQ_D_PCFD1803_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)
3fvc GLYCOPROTEIN GP110
(Human
gammaherpesvirus
4)
4 / 7 SER A 314
THR A 311
HIS A  77
ILE A 307
None
1.03A 5vkqC-3fvcA:
undetectable
5vkqD-3fvcA:
undetectable
5vkqC-3fvcA:
17.06
5vkqD-3fvcA:
17.06